Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis

DOI Web Site 4 Citations
  • C Solaro
    Department of Social and Health Services and Research, Italian M.S. Society, Italy, Department of Neurological Sciences and Rehabilitation, University of Genoa, Genoa, Italy
  • M Messmer Uccelli
    Department of Social and Health Services and Research, Italian M.S. Society, Italy
  • P Guglieri
    Department of Social and Health Services and Research, Italian M.S. Society, Italy
  • A Uccelli
    Department of Neurological Sciences and Rehabilitation, University of Genoa, Genoa, Italy
  • G L Mancardi
    Department of Neurological Sciences and Rehabilitation, University of Genoa, Genoa, Italy

Search this article

Description

<jats:p> In-patients with MS nocturnal spasms (NPS) occur frequently, primarily during the night and may influence the ability to and/or quality of sleep. We enrolled in an open label trial with GBP (up to 600 mg/day) 24 MS patients with NPS. We obtained patient reports of subjective discomfort at pre-treatment and following 2- (T1) and 8 weeks (T2), utilizing a 3-point analogue scale. Twenty of the 22 patients who completed the study reported resolution or amelioration of discomfort. Clinical improvement occurred 1-5 days following initial treatment. Three patients experienced adverse effects but completed the minimal follow-up period (2 weeks). Two patient dropped out of the study due to no compliance or adverse effects. A very low dose of GBP may be effective treatment for MS patients with NPS who may benefit from rapid improvement of discomfort with minimal risk of adverse effects. </jats:p>

Journal

Citations (4)*help

See more

Details 詳細情報について

Report a problem

Back to top